NO963128L - Middel for transdermal applikasjon inneholdende 14, 17-etanoöstra-1,3,5(10)-trien-3, 17-diol - Google Patents

Middel for transdermal applikasjon inneholdende 14, 17-etanoöstra-1,3,5(10)-trien-3, 17-diol

Info

Publication number
NO963128L
NO963128L NO963128A NO963128A NO963128L NO 963128 L NO963128 L NO 963128L NO 963128 A NO963128 A NO 963128A NO 963128 A NO963128 A NO 963128A NO 963128 L NO963128 L NO 963128L
Authority
NO
Norway
Prior art keywords
diol
agent
ostra
ethano
trien
Prior art date
Application number
NO963128A
Other languages
English (en)
Norwegian (no)
Other versions
NO963128D0 (no
Inventor
Clemens Gunther
Ralph Lipp
Ulrich Tauber
Jutta Riedl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO963128L publication Critical patent/NO963128L/no
Publication of NO963128D0 publication Critical patent/NO963128D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO963128A 1994-01-27 1996-07-26 Middel for transdermal applikasjon inneholdende 14, 17-etanoöstra-1,3,5(10)-trien-3, 17-diol NO963128D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1994/000213 WO1995020392A1 (de) 1994-01-27 1994-01-27 MITTEL ZUR TRANSDERMALEN APPLIKATION ENTHALTEND 14α,17α-ETHANOESTRA-1,3,5(10)-TRIEN-3,17β-DIOL

Publications (2)

Publication Number Publication Date
NO963128L true NO963128L (no) 1996-07-26
NO963128D0 NO963128D0 (no) 1996-07-26

Family

ID=8165820

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963128A NO963128D0 (no) 1994-01-27 1996-07-26 Middel for transdermal applikasjon inneholdende 14, 17-etanoöstra-1,3,5(10)-trien-3, 17-diol

Country Status (6)

Country Link
EP (1) EP0741572A1 (fi)
JP (1) JPH09510697A (fi)
AU (1) AU5971294A (fi)
FI (1) FI962993A (fi)
NO (1) NO963128D0 (fi)
WO (1) WO1995020392A1 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
EP1443964B1 (en) * 2001-11-09 2008-02-20 QLT Inc. Photodynamic therapy for the treatment of hair loss

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883669A (en) * 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
CH674618A5 (fi) * 1987-04-02 1990-06-29 Ciba Geigy Ag
WO1990004397A1 (de) * 1988-10-27 1990-05-03 Schering Aktiengesellschaft Berlin Und Bergkamen Mittel zur transdermalen applikation enthaltend gestoden
DE3838779A1 (de) * 1988-11-11 1990-05-17 Schering Ag 14(alpha),17(alpha)-ethano-estratriene
DE4227989A1 (de) * 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel

Also Published As

Publication number Publication date
AU5971294A (en) 1995-08-15
EP0741572A1 (de) 1996-11-13
FI962993A0 (fi) 1996-07-26
JPH09510697A (ja) 1997-10-28
WO1995020392A1 (de) 1995-08-03
NO963128D0 (no) 1996-07-26
FI962993A (fi) 1996-07-26

Similar Documents

Publication Publication Date Title
NO950626L (no) Middel for transdermal applikasjon inneholdende 3-ketodesogestrel
IS5241A (is) (Heteró) hringsetin asýlanilíð sem eru ekki steróíðar með blandaða gestagen og andrógen virkni
NO845194L (no) Flertrinnskombinasjonspreparat og anvendelse av dette som oralt antikonsepsjonsmiddel
DE69839893D1 (de) Anti-östrogene Steroide, pharmazeutische Zusammensetzungen und Verwendungen davon
WO1999012531A3 (de) Mittel zur hormonalen kontrazeption
HUP9903515A3 (en) 21-substituted progesterone derivatives as new antiprogestational agents medicoments containing the same, use thereof
BR0106127A (pt) Artigo absorvente de múltiplas funções
TR199902205T2 (xx) Lipofilik bir at�l gaz ihtiva eden t�bb� terkip.
ZA200007299B (en) Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol.
ID29190A (id) Alat pengantaran obat, terutama untuk pengantaran progestin dan estrogen
CA2001618A1 (en) Gestodene-containing agent for transdermal administration
ZA974981B (en) A novel composition for transdermal administration of an estrogen, a progestin or a mixture thereof.
DK2399582T3 (da) Selektiv østrogenreceptormodulator i kombination med dehydroepiandrosteron (DHEA) eller analoger
DK0771217T3 (da) Faste lægemiddelformer, som indeholder clathrater af det steroide könshormon ethinylestadiol
BR9707211A (pt) Dispositivo para abertura de cápsula para uso em um inalador de pó
BR0208464A (pt) Aperfeiçoamentos em ou referentes a dispositivos purificadores de ar
BR9709021A (pt) Composição detergente e uso da mesma.
SE9400631L (sv) Anordning vid protetisk konstruktionsenhet och implantat
PT956022E (pt) Composicao hormonal constituida por um composto estrogeno e por um composto progestativo
NO963128L (no) Middel for transdermal applikasjon inneholdende 14, 17-etanoöstra-1,3,5(10)-trien-3, 17-diol
NO963433L (no) Middel for transdermal applisering inneholdende desogestrel
PL1635843T3 (pl) Hormonalna terapia zastępcza i leczenie depresji obejmujące dienogest
Buyon et al. Recommendations for exogenous estrogen to prevent glucocorticoid-induced osteoporosis in premenopausal women with oligo-or amenorrhea: comment on the American College of Rheumatology recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis
BR0115374A (pt) Porta-implementos
宋健 Dismissing Doubts andClearing Away Confusions─ Outline of Speech Delivered at the Seminar Initiatingthe Xia-Shang-Zhou Chronology Project, 16 May 1996